- Home
- Home
- Supplements
- L-Phenylalanine
L-Phenylalanine
L-Phenylalanine
TL;DR
L-phenylalanine is the essential precursor to tyrosine, dopamine and noradrenaline. Its best-supported use is in medically supervised phototherapy for vitiligo; mood claims rest on old, low-quality trials.
Ideal For
- People undergoing supervised UVA phototherapy for vitiligo
Avoid If
- You have phenylketonuria — absolute contraindication
- You take an MAO inhibitor
- You have uncontrolled high blood pressure
- You have a history of melanoma or significant photosensitivity
Frequently Asked Questions
Overview
L-phenylalanine is essential and abundant in dietary protein. Hydroxylated to tyrosine, it feeds the catecholamine pathway, which is the mechanistic story behind mood and focus marketing. The evidence for that use is weak: the antidepressant trials date from the 1970s and 1980s, are small, mostly uncontrolled, and would not pass modern review. Where it has held up better is vitiligo, where oral L-phenylalanine combined with UVA phototherapy produced repigmentation in several controlled studies — a niche but real indication, and one that requires dermatological supervision. DL-phenylalanine, the racemic mix, is separately promoted for chronic pain on the theory that the D-isomer inhibits enkephalin breakdown; human trials for this are small and conflicting. The absolute contraindication is phenylketonuria, where the enzyme converting phenylalanine to tyrosine is deficient and accumulation causes neurological damage — this is why aspartame carries a PKU warning. For people wanting a catecholamine precursor without the PKU issue and with more trial data, L-tyrosine is the better-studied option.
How It Works
- Hydroxylated by phenylalanine hydroxylase to tyrosine, the direct precursor to L-DOPA and dopamine
- Feeds noradrenaline and adrenaline synthesis downstream of dopamine
- Stimulates melanocyte activity when combined with UVA exposure, the basis of the vitiligo protocol
- D-isomer may inhibit enkephalinase, prolonging endogenous opioid signalling
Benefits & Outcomes
No linked outcomes yet. Research is ongoing.
Health Concerns Addressed
Vitiligo
Combined with UVA phototherapy, oral L-phenylalanine produced meaningful repigmentation in controlled studies. It does almost nothing on its own.
Chronic Pain
The enkephalinase theory is interesting but the human trials are tiny, old and contradictory. There is no reliable analgesic effect.
Supporting Research5 studies
Key European guidelines for the diagnosis and management of patients with phenylketonuria
van Spronsen FJ, van Wegberg AM, Ahring K
Phenylalanine intake must be strictly restricted lifelong in phenylketonuria because elevated blood phenylalanine is neurotoxic.
L-phenylalanine and UVA irradiation in the treatment of vitiligo
Siddiqui AH, Stolk LM, Bhaggoe R
L-phenylalanine with UVA produced significantly greater facial repigmentation than UVA alone.
Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience
Camacho F, Mazuecos J
Oral and topical phenylalanine with light exposure produced repigmentation in most vitiligo patients over six years of practice.
Phenylalanine and UVA light for the treatment of vitiligo
Cormane RH, Siddiqui AH, Westerhof W
Phenylalanine combined with UVA exposure produced repigmentation in a majority of treated vitiligo patients.
DL-phenylalanine versus imipramine: a double-blind controlled study
Beckmann H, Athen D, Olteanu M
DL-phenylalanine produced antidepressant effects comparable with imipramine in a small 1970s inpatient trial.
Safety Information
Potential Side Effects
Headache, anxiety, insomnia, nausea and heartburn. Blood pressure can rise, particularly in combination with stimulants.
Contraindications
Phenylketonuria, MAOI use, uncontrolled hypertension, pregnancy.
Drug Interactions
- MAO inhibitors — hypertensive crisis risk
- Levodopa — competes for the same transporter and can reduce efficacy
- Antipsychotics — theoretical risk of worsening tardive dyskinesia
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
Consult healthcare provider
Forms Compared
Food & Timing
On an empty stomach, away from other amino acids that compete for the same transporter.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.